United States

Vernalis PLC (VER.L)

VER.L on London Stock Exchange

24 Jul 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Vernalis Plc issues a complete response letter on CCP-07 NDA
Friday, 21 Apr 2017 02:00am EDT 

April 21 (Reuters) - Vernalis Plc :Vernalis Plc: FDA issues a complete response letter on CCP-07 NDA.CRL did not raise any concerns with formulation or pharmacokinetic profile of CCP-07.CRL did identify outstanding items that need to be addressed prior to resubmission and approval of NDA.  Full Article

Vernalis Plc enters drug discovery collaboration with Servier
Monday, 6 Mar 2017 02:10am EST 

Vernalis Plc : New drug discovery collaboration with servier .Will receive EUR 2 million upfront payment, fees, research milestones and share in downstream success of any products out of collaboration.  Full Article

Vernalis says U.S. FDA accepts CCP-08 new drug application for full review
Wednesday, 21 Dec 2016 02:13am EST 

Vernalis Plc : FDA accepts CCP-08 NDA for full review .Triggers a milestone payment from Vernalis to Tris.  Full Article

Vernalis says cash position ahead of market expectations
Thursday, 7 Jul 2016 08:47am EDT 

Vernalis Plc : Company's unaudited cash position (including cash and cash equivalents and held to maturity assets), at June 30, was 84 mln stg . Cash position is ahead of market expectations and reflects favourable impact of recent strengthening of U.S. dollar since UK referendum vote .At year-end 73 pct of company's cash was held in U.S. dollars.  Full Article